Search

PreveCol®, a blood test for oncological diagnosis, has obtained US recognition for its efficacy in detecting precancerous lesions compared to existing alternatives in the United States.

Meet BIOXYTOL, our new member. We talked its with Kamaljit S. Sood, CEO.

Meet THYTECH, our new member. We talked to its Rafael Correa-Rocha, Director & Co-Founder.

The event will feature a brief review of the topline results of the Phase IIb PORTICO study, then a discussion with experts.

The technical meeting and collaborative forum have been held under the title "Applications of non-viral vectors in gene editing and therapy: Challenges for academia and industry."

This initiative aims to have a positive long term impact on the environment, economy and society by helping achieve 10 of the Sustainable Development Goals (SDG).

January 10th, in an event with numerous institutional representatives, headed by the Lehendakari Iñigo Urkullu, together with representatives from the business, financial, scientific-technological and